Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life
Corporate - Media & Press - Press Release
Dr. Schena receives Oxford recognition.
Sunnyvale, CA, April 10, 2003 – On April 8th Oxford University Press announced that “DNA Microarrays: A Practical Approach” edited by Dr. Mark Schena is the best selling book of the in-print titles of Oxford’s Practical Approach Series. Dr. Schena published “DNA Microarrays” in 1999, under the guidance of Dr. David Hames from the University of Leeds.
Oxford University Press (OUP) was founded in 1668 as a department in the University of Oxford, the oldest English-speaking University in the world. Teaching at Oxford dates back to the year 1096, and over the centuries the University has educated at the very highest level. Distinguished Oxford graduates include Lawrence of Arabia, Prime Minister Indira Gandhi, Prime Minister Margaret Thatcher, President Bill Clinton, Prime Minister Tony Blair, actor Hugh Grant, and physicist Stephen Hawking.
Dr. Schena had this to say about the Oxford announcement. “David contacted me at a relatively early stage of the field, and I agreed to the editorship not knowing how successful the project would be. With over 200 titles in the Practical Approach series, it is surprising to have edited the best selling book, and I must say that the contributors deserve most of the credit for the success of DNA Microarrays. It is also a great honor to have a connection to Oxford Press and the University of Oxford, in light of all the distinguished graduates.”
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley. Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications. Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services. The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.
Copyright 1993-2019 Arrayit Corporation. All rights reserved.